Lexicon Pharmaceuticals
LXRX
$0.57
Share price
-7.87%
Change (1 day)
-83.73%
Change (1 year)
Categories
EPS for Lexicon Pharmaceuticals (LXRX)
EPS in 2023 (TTM): -$1.11
According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.19. In 2022 the company made an earnings per share (EPS) of -$1.07 an increase over its 2021 EPS that were of -$1.07.
EPS history for Lexicon Pharmaceuticals from 2000 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.11 | 4.38% |
| 2022 | -$1.07 | -0% |
| 2021 | -$1.07 | 10.91% |
| 2020 | -$0.96 | -145.08% |
| 2019 | $2.13 | -206.09% |
| 2018 | -$2.01 | -5.74% |
| 2017 | -$2.13 | -10.95% |
| 2016 | -$2.39 | 2640% |
| 2015 | -$0.08734 | -96.34% |
| 2014 | -$2.38 | -2.53% |
| 2013 | -$2.45 | -9.09% |
| 2012 | -$2.69 | -37.14% |
| 2011 | -$4.28 | 0% |
| 2010 | -$4.28 | -39.66% |
| 2009 | -$7.09 | 3.57% |
| 2008 | -$6.85 | -8.2% |
| 2007 | -$7.46 | -24.69% |
| 2006 | -$9.90 | 42.11% |
| 2005 | -$6.97 | -22.97% |
| 2004 | -$9.05 | -35.09% |
| 2003 | -$13.94 | -0% |
| 2002 | -$13.94 | 62.86% |
| 2001 | -$8.56 | -19.54% |
| 2000 | -$10.64 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$9.85 | 729.41% | 🇺🇸 USA |
 | $65.26 | -5,594.12% | 🇺🇸 USA |
 | -$17.89 | 1,405.88% | 🇺🇸 USA |
 | $1.36 | -214.51% | 🇺🇸 USA |
 | $26.79 | -2,355.88% | 🇺🇸 USA |
 | -$4.93 | 314.71% | 🇺🇸 USA |
 | -$46.48 | 3,813.24% | 🇺🇸 USA |
 | $2.74 | -330.88% | 🇺🇸 USA |
 | -$1.31 | 10.29% | 🇺🇸 USA |